vs
Side-by-side financial comparison of enCore Energy Corp. (EU) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Entrada Therapeutics, Inc. is the larger business by last-quarter revenue ($20.6M vs $12.4M, roughly 1.7× enCore Energy Corp.). Entrada Therapeutics, Inc. runs the higher net margin — -84.4% vs -173.9%, a 89.5% gap on every dollar of revenue. enCore Energy Corp. produced more free cash flow last quarter ($7.2M vs $-39.7M).
Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
EU vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.4M | $20.6M |
| Net Profit | $-21.5M | $-17.3M |
| Gross Margin | 37.9% | — |
| Operating Margin | -135.9% | -106.0% |
| Net Margin | -173.9% | -84.4% |
| Revenue YoY | — | -65.2% |
| Net Profit YoY | — | -173.8% |
| EPS (diluted) | $-0.11 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.4M | — | ||
| Q3 25 | $8.9M | — | ||
| Q2 25 | $3.7M | — | ||
| Q1 25 | $18.2M | $20.6M | ||
| Q4 24 | — | $37.4M | ||
| Q3 24 | — | $19.6M | ||
| Q2 24 | — | $94.7M | ||
| Q1 24 | — | $59.1M |
| Q4 25 | $-21.5M | — | ||
| Q3 25 | $-4.8M | — | ||
| Q2 25 | $-6.3M | — | ||
| Q1 25 | $-24.2M | $-17.3M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $-14.0M | ||
| Q2 24 | — | $55.0M | ||
| Q1 24 | — | $23.5M |
| Q4 25 | 37.9% | — | ||
| Q3 25 | 43.8% | — | ||
| Q2 25 | 30.8% | — | ||
| Q1 25 | -0.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -135.9% | — | ||
| Q3 25 | -158.2% | — | ||
| Q2 25 | -526.1% | — | ||
| Q1 25 | -85.7% | -106.0% | ||
| Q4 24 | — | -15.7% | ||
| Q3 24 | — | -110.7% | ||
| Q2 24 | — | 56.4% | ||
| Q1 24 | — | 35.7% |
| Q4 25 | -173.9% | — | ||
| Q3 25 | -53.7% | — | ||
| Q2 25 | -172.7% | — | ||
| Q1 25 | -132.9% | -84.4% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | -71.7% | ||
| Q2 24 | — | 58.1% | ||
| Q1 24 | — | 39.7% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $-0.03 | — | ||
| Q1 25 | $-0.13 | $-0.42 | ||
| Q4 24 | — | $-0.20 | ||
| Q3 24 | — | $-0.35 | ||
| Q2 24 | — | $1.55 | ||
| Q1 24 | — | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | $67.8M |
| Total DebtLower is stronger | $110.0M | — |
| Stockholders' EquityBook value | $229.2M | $417.3M |
| Total Assets | $430.4M | $486.5M |
| Debt / EquityLower = less leverage | 0.48× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | — | ||
| Q3 25 | $91.9M | — | ||
| Q2 25 | $26.9M | — | ||
| Q1 25 | $29.7M | $67.8M | ||
| Q4 24 | — | $101.2M | ||
| Q3 24 | — | $78.0M | ||
| Q2 24 | — | $185.3M | ||
| Q1 24 | — | $68.4M |
| Q4 25 | $110.0M | — | ||
| Q3 25 | $109.3M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $229.2M | — | ||
| Q3 25 | $248.6M | — | ||
| Q2 25 | $264.7M | — | ||
| Q1 25 | $267.9M | $417.3M | ||
| Q4 24 | — | $428.7M | ||
| Q3 24 | — | $422.4M | ||
| Q2 24 | — | $429.9M | ||
| Q1 24 | — | $269.4M |
| Q4 25 | $430.4M | — | ||
| Q3 25 | $441.9M | — | ||
| Q2 25 | $359.4M | — | ||
| Q1 25 | $362.6M | $486.5M | ||
| Q4 24 | — | $526.3M | ||
| Q3 24 | — | $554.6M | ||
| Q2 24 | — | $582.0M | ||
| Q1 24 | — | $510.8M |
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.44× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.9M | $-38.5M |
| Free Cash FlowOCF − Capex | $7.2M | $-39.7M |
| FCF MarginFCF / Revenue | 57.8% | -192.9% |
| Capex IntensityCapex / Revenue | 46.7% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.0M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.9M | — | ||
| Q3 25 | $-20.3M | — | ||
| Q2 25 | $-9.9M | — | ||
| Q1 25 | $-7.7M | $-38.5M | ||
| Q4 24 | — | $-31.6M | ||
| Q3 24 | — | $-24.3M | ||
| Q2 24 | — | $39.8M | ||
| Q1 24 | — | $-25.5M |
| Q4 25 | $7.2M | — | ||
| Q3 25 | $-26.3M | — | ||
| Q2 25 | $-14.1M | — | ||
| Q1 25 | $-11.7M | $-39.7M | ||
| Q4 24 | — | $-32.2M | ||
| Q3 24 | — | $-24.9M | ||
| Q2 24 | — | $38.8M | ||
| Q1 24 | — | $-26.4M |
| Q4 25 | 57.8% | — | ||
| Q3 25 | -296.6% | — | ||
| Q2 25 | -385.2% | — | ||
| Q1 25 | -64.1% | -192.9% | ||
| Q4 24 | — | -86.2% | ||
| Q3 24 | — | -127.3% | ||
| Q2 24 | — | 41.0% | ||
| Q1 24 | — | -44.6% |
| Q4 25 | 46.7% | — | ||
| Q3 25 | 68.0% | — | ||
| Q2 25 | 115.1% | — | ||
| Q1 25 | 21.7% | 5.6% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
